New oral diabetes + obesity drug's India sales surge 100%
India experiences a surge in Rybelsus sales, impacting the anti-obesity market. Semaglutide dominates, reflecting India's obesity challenges and evolving disease patterns as it grows as a superpower.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Diabetes | Eating Disorders & Weight Management | Endocrinology | India Health | Obesity | Pharmaceuticals